Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 20.07% vs 4.41% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 43.96% vs -8.03% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 40.96% vs 0.12% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -33.33% vs -25.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 11.25% vs 19.67% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 20.07% vs 4.41% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 38.13% vs 71.29% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 43.96% vs -8.03% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 31.80% vs 64.15% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 40.96% vs 0.12% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -33.33% vs -25.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






